Literature DB >> 473592

Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza viruses: nonrandom reassortment of genes during preparation of live virus vaccine candidates by recombination at 25 degrees between recent H3N2 and H1N1 epidemic strains and cold-adapted A/An Arbor/6/60.

N J Cox, H F Maassab, A P Kendal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 473592     DOI： 10.1016/0042-6822(79)90386-6

Source DB:  PubMed          Journal:  Virology        ISSN： 0042-6822            Impact factor:   3.616


× No keyword cloud information.
  20 in total

1.  Evaluation of a cold-adapted influenza B/Texas/84 reassortant virus (CRB-87) vaccine in young children.

Authors:  E L Anderson; F K Newman; H F Maassab; R B Belshe
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

2.  The immunogenicity of reassortants of the cold-adapted influenza A master strain A/Ann Arbor/6/60 is determined by both the genes for cold-adaptation and the haemagglutinin gene.

Authors:  G A Tannock; J R Romanova; J A Paul
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

3.  Biological characteristics of a cold-adapted influenza A virus mutation residing on a polymerase gene.

Authors:  T Odagiri; A Tosaka; N Ishida; H F Maassab
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

4.  Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines.

Authors:  M H Snyder; R F Betts; D DeBorde; E L Tierney; M L Clements; D Herrington; S D Sears; R Dolin; H F Maassab; B R Murphy
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

5.  Cold-adapted reassortants of influenza A virus: pathogenicity of A/Ann Arbor/6/60 X A/Alaska/6/77 reassortant viruses in vivo and in vitro.

Authors:  A W Heath; H F Maassab; T Odagiri; D C DeBorde; C W Potter
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

6.  Evaluation of A/Alaska/6/77 (H3N2) cold-adapted recombinant viruses derived from A/Ann Arbor/6/60 cold-adapted donor virus in adult seronegative volunteers.

Authors:  B R Murphy; R M Chanock; M L Clements; W C Anthony; A J Sear; L A Cisneros; M B Rennels; E H Miller; R E Black; M M Levine; R F Betts; R G Douglas; H F Maassab; N J Cox; A P Kendal
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

7.  Safety of and serum antibody response to cold-recombinant influenza A and inactivated trivalent influenza virus vaccines in older adults with chronic diseases.

Authors:  G J Gorse; R B Belshe; N J Munn
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

8.  Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus.

Authors:  M L Clements; S O'Donnell; M M Levine; R M Chanock; B R Murphy
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

9.  Studies with some influenza B viruses in cell cultures, hamsters and hamster tracheal organ cultures.

Authors:  P Reeve; M Pibermann; B Gerendas
Journal:  Med Microbiol Immunol       Date:  1981       Impact factor: 3.402

10.  Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines.

Authors:  B R Murphy; D L Nelson; P F Wright; E L Tierney; M A Phelan; R M Chanock
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.